Press Releases

Phastar Statistics Manager Wins Prestigious DIA Award

Phastar Statistics Manager Wins Prestigious DIA Award Stephen Corson chosen to receive the DIA 2023 Global Inspire Award for Community Engagement. London, UK and Durham, NC – 6 June 2023: Stephen Corson, Statistics Manager at specialist biometrics contract research organization (CRO) Phastar, has been chosen to receive the DIA 2023 Global Inspire Award for Community Engagement.

Mural Health and ClinOne Partner to Maximize Patient Experience While Minimizing Site Burden

Mural Health and ClinOne Partner to Maximize Patient Experience While Minimizing Site Burden Strategic partnership integrates next-generation patient support and payment solutions for participants and sites alike

BioIVT to Host an Advanced In Vitro ADME Strategies Symposium in Copenhagen

Presenters will discuss the ICH M12 Drug Interaction Studies Guideline, and novel ADME models and methodologies.

Abzena appoints Thomas Castellano as Chief Financial Officer

Abzena, the leading end-to-end integrated CDMO for complex biologic molecules and Antibody Drug Conjugates (ADCs) has announced the appointment of Thomas Castellano, as Chief Financial Officer.

Inizio launches strategic engagement offering to transform customer experiences

Samsung Biologics and Pfizer announce strategic collaboration for long-term manufacturing of biosimilars portfolio

Test Environment as a Service Market is anticipated to register a CAGR of 23.5% during the forecast period.

Test Environment as a Service Market is anticipated to register a CAGR of 23.5% during the forecast period.The global test environment as a service market is expected to register moderate growth over the forecast period. This is attributed to Increasing adoption of test environment as a service, owing to it allows speeding up software release schedules, to cut infrastructure costs, and increase team productivity. Furthermore, rising utilization of test environment as a service for testing services drives growth of the global test environment as a service market.

AARDEX Partners with Mevia to Test Evolution of Real-Time Adherence Technology

AARDEX Partners with Mevia to Test Evolution of Real-Time Adherence Technology Integration of AARDEX MEMS AS and MEMS Mobile technology with Mevia's Medose dispenser offers opportunity to pilot next stage in reusable and real-time adherence solutions.

Purolite Grows Bioprocessing Production Capacity with New U.S. Manufacturing Facility

Landenberg site strengthens supply to support lifesaving therapeutics for global customers

Xlpe Cable Market is estimated to be US$ 3.09 billion by 2030 with a CAGR of 6.2% during the forecast period

The Xlpe cables market accounted for US$ 1.70 billion in 2020 and is estimated to be US$ 3.09 billion by 2030 and is anticipated to register a CAGR of 6.2%. Cross linked polyethylene insulated aluminium conductor armoured cable is referred to as XLPE cable. It is a fundamental necessity of power networks used in the transmission and distribution of electricity to consumers. These cables are categorised into four voltage groups based on their application: low voltage, medium voltage, high voltage, and extra-high voltage, and are used in transmission lines ranging from 600V to 1000 kV.XLPE cables are utilised for extended distances where dielectric losses are significant. These cables have a higher insulation value, are lighter, and have a higher current capacity.

Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025

Quanticate announces strategic partnership with KPS Life

Cmed and Larix fully integrated into Aixial Group, the CRO solution of ALTEN Group

Kristin Judge Joins Emmes as Chief Growth Officer

Notes to Editor: About Emmes Founded more than 45 years ago, Emmes is a global, full-service Clinical Research Organization dedicated to excellence in supporting the advancement of public health and biopharmaceutical innovation. The company’s clients include numerous agencies and institutes of the U.S. federal government and a wide range of biotechnology, pharmaceutical and medical device companies throughout the world. To learn more about how our research is making a positive impact on human health, go to the Emmes website at www.emmes.com. For media enquiries, please contact: Alex Heeley or Nidhi Narain De Facto Communications T: +44 (0) 203 735 8165 / +44 (0) 7769015043 E: n.narain@defacto.co.uk / a.heeley@defacto.co.uk

CTMC MARKS ONE YEAR OF ACCELERATING LIFE-SAVING CELL THERAPIES TO PATIENTS

CTMC, a joint venture between MD Anderson Cancer Center and Resilience, celebrates one year since its founding to accelerate life-saving cell therapies reaching patients.

Biopharma PEG Supplies PEG Products For 3D Bioprinting

Biopharma PEG Scientific Inc. Address: 108 Water Street, Room 4D, Watertown, MA 02472, USA TEL: 1-857-366-6766 Fax: 617-206-9595 Email: sales@biochempeg.com Website:https://www.biochempeg.com/

Amerigo Scientific Distributes Highly Purified Human tRNA Reagents to Accelerate HIV Research

Huateng Pharma Announced To Attend CPhI China In June 2023

Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818

CD Formulation Exhibits Proficiency in Contact Angle Determination of Pharmaceutical Excipients

Synexa Life Sciences Joins CEPI in Advancing Global Epidemic Preparedness and Response

Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, has announced its membership in the Coalition for Epidemic Preparedness Innovations (CEPI) esteemed Central Lab Network, to improve global epidemic preparedness. CEPI is an innovative partnership between public, private, philanthropic, and civil organizations to develop vaccines against future epidemics. This strategic partnership represents a significant milestone in Synexa's commitment to global health security and its dedication to fostering collaboration and innovation in epidemic preparedness and response.